jump to navigation

D-Pharm Raises $10 Million Clal Biotechnology, Israel Healthcare Ventures & Pitango May 15, 2006

Posted by israelhealthcare in Drug Discovery.
trackback

Biopharmaceutical Company D-Pharm has raised $10 million in a private round of financing. The round was led by Clal Biotechnology Industries, Israel Healthcare Ventures Pitango Venture Capital, and existing investors: Care Capital, Gemini, and Polar Communications.

“These resources will enable us to fund the further development of our main product, DP-b99 for acute stroke currently in Phase 2 clinical trials, as well as to complete pre-clinical development of our lead candidate for Alzheimer’s disease,” said Dr. Alexander Kozak, D-Pharm’s Founder, Chief Executive Officer and President.

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company’s offices, research and development laboratories and pilot manufacturing plant are located in the Kiryat Weizmann Science Park in Nes Ziona, Israel.

Advertisements

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: